Sabra Healthcare REIT, Inc. $SBRA Shares Sold by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans lowered its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRAFree Report) by 39.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 499,282 shares of the real estate investment trust’s stock after selling 331,241 shares during the quarter. Thrivent Financial for Lutherans owned 0.20% of Sabra Healthcare REIT worth $9,456,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Founders Capital Management acquired a new stake in shares of Sabra Healthcare REIT during the third quarter valued at approximately $28,000. Strengthening Families & Communities LLC acquired a new position in Sabra Healthcare REIT in the 4th quarter valued at approximately $29,000. Danske Bank A S acquired a new position in Sabra Healthcare REIT in the 3rd quarter valued at approximately $30,000. Larson Financial Group LLC increased its stake in Sabra Healthcare REIT by 42.3% in the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after buying an additional 553 shares during the period. Finally, First Horizon Corp acquired a new position in Sabra Healthcare REIT in the 4th quarter valued at approximately $44,000. Institutional investors and hedge funds own 99.40% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on SBRA. Wall Street Zen upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Monday. Scotiabank upped their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “sector perform” rating in a research note on Monday, March 2nd. Cantor Fitzgerald upped their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Monday, May 11th. Citizens Jmp upped their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research note on Wednesday, February 18th. Finally, Wells Fargo & Company upped their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company an “overweight” rating in a research note on Thursday, March 26th. Five analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $22.20.

Read Our Latest Analysis on SBRA

Sabra Healthcare REIT Price Performance

NASDAQ SBRA opened at $21.01 on Wednesday. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. The company has a fifty day simple moving average of $20.31 and a 200 day simple moving average of $19.58. The company has a market cap of $5.30 billion, a P/E ratio of 33.35, a P/E/G ratio of 1.67 and a beta of 0.67. Sabra Healthcare REIT, Inc. has a 1 year low of $17.08 and a 1 year high of $21.28.

Sabra Healthcare REIT (NASDAQ:SBRAGet Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The firm had revenue of $221.75 million during the quarter, compared to the consensus estimate of $209.20 million. During the same period in the prior year, the firm earned $0.37 EPS. The business’s revenue was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, sell-side analysts predict that Sabra Healthcare REIT, Inc. will post 1.5 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 29th. Investors of record on Friday, May 15th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.7%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 190.48%.

Sabra Healthcare REIT Profile

(Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

Featured Articles

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRAFree Report).

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.